Research map: Reassessing the OX40 / OX40L axis in atopic dermatitis after the termination of Rocatinlimab's clinical development program

Back to the article

Papers in this map

  1. OX40 / OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders · Aditya Kumar Gupta · 2026 · 4 citations · Cited by this paper
  2. Medical history questionnaire in suspected intolerance to metal and non‐metal implants · 2026 · Related
  3. Targeting OX40: rocatinlimab—a novel therapy for atopic dermatitis · Keneshka Atash · 2025 · 1 citation · Cited by this paper
  4. Occupational eyelid dermatitis: A public health perspective · 2026 · Related
  5. Editor’s Picks August 2026 · 2026 · Related
  6. Estimating the global burden of mental health disorders associated with atopic dermatitis · 2026 · Related
  7. Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN · 2026 · Related
  8. Adult‐presenting verrucous eccrine naevus of the forehead · 2026 · Related
  9. Bridging the gap between the clinical need and drug approval in paediatric auto immune blistering diseases · 2026 · Related
  10. Cutaneous neonatal lupus associated with anti‐ U1RNP antibodies · 2026 · Related
  11. Recurrent antibiotic burden during adalimumab therapy in hidradenitis suppurativa · 2026 · Related
  12. Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages · 2026 · Related

Source: OpenAlex (CC0)